New Treatments and a Turning Point in Fatty Liver Disease Care with Dr. Meena Bansal
About this episode
Dr. Meena Bansal discusses new treatments and the future of care for fatty liver disease.
In this episode, Meena Bansal, MD, FAASLD - System Chief, Division of Liver Diseases Director, MASH/NASH Center of Excellence, Icahn School of Medicine at Mount Sinai, discusses newly approved therapies for MASH and the growing impact of GLP-1 medications. She also shares insights on personalized treatment, early intervention, and the future of liver disease care.
More episodes of Becker’s Healthcare - Clinical Leadership Podcast
- Reframing Pediatric Palliative Care Through Compassionate, Family Centered Support with Dr. Carla Cangemi
- Advancing Cardiovascular Innovation and Leadership in Modern Medicine with Dr. Joseph Rogers
- Stacey Conklin, CNO of Montefiore Nyack Hospital
- Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program
- Rebecca Baute, BSN, RN, Chief Nurse Executive of Northwestern Medicine Palos Hospital, and Brittany Barasa, DNP, RN, Manager of Patient Care for Nursing Throughput and PCT Float Pool
- Kenny Cole, MD, System Vice President of Clinical Improvement at Ochsner Health System
Explore listener stats, chart rankings, contacts and more on the Becker’s Healthcare - Clinical Leadership Podcast podcast page.